NEW YORK, Aug. 18, 2021 (GLOBE NEWSWIRE) — Read more »
Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf Region
"" Bylvay is approved in the U.S. and EU as only once–daily drug indicated for patients with PFIC ""
"" PFIC is a life–threatening [...] Read more »